Phytomedicine 1994; 1: 245–254
Melchart D, Linde K, Worku F, Bauer R, Wagner H
We performed a systematic review of controlled clinical trials to
check the evidence for the immunomodulatory efficacy of
preparations containing extracts of Echinaacea. Trials were
searched by on-line searches in Medline and Embase, a search in
the private database Phytodok, contacts with researchers and drug
companies, and by checking references in available articles. All
available historically and prospectively controlled trials
investigating the prophylactic or therapeutic immunomodulatory
activity of preparations of Echinacea alone or in combination
with other plant extracts or homeopathic dilutions in humans were
included. Study characteristics, results, and conclusions of
primary authors were analyzed using standardized evaluation forms
and methodological quality assessment using a predefined score
system.
A total of 26 controlled clinical trials (18 randomized, 11
double-blind) were identified; 6 of these involved testing three
different mono-extracts, and 20 involved testing three different
preparations also containing other ingredients. Nineteen trials
studied the efficacy of the prophylactic or curative treatment of
infections; 4 trials the reduction of side-effects of
antineoplastic therapies and 3 trials the modulation of various
laboratory immune parameters. The primary authors claimed that 30
of the 34 treatment strategies showed a superior efficacy to
those of the control groups. The methodological quality of most
studies was low and only 8 trials scored more than half of the
maximum possible score points.
Existing controlled clinical trials indicate that preparations
containing extracts of Echinacea can be efficacious
immunomodulators. However, the evidence is still insufficient for
clear therapeutic recommendations as to which preparation to use
and which dose to employ for a specific indication. Further
methodologically sound, randomized clinical trials should be
conducted.